High-dose erythropoietin in patients with progressive multiple sclerosis: A randomized, placebo-controlled, phase 2 trial
出版年份 2016 全文链接
标题
High-dose erythropoietin in patients with progressive multiple sclerosis: A randomized, placebo-controlled, phase 2 trial
作者
关键词
-
出版物
Multiple Sclerosis Journal
Volume 23, Issue 5, Pages 675-685
出版商
SAGE Publications
发表日期
2016-08-02
DOI
10.1177/1352458516661048
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effects of Erythropoietin on Hippocampal Volume and Memory in Mood Disorders
- (2015) Kamilla W. Miskowiak et al. BIOLOGICAL PSYCHIATRY
- Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives
- (2015) Daniel Ontaneda et al. LANCET NEUROLOGY
- Pathological mechanisms in progressive multiple sclerosis
- (2015) Don H Mahad et al. LANCET NEUROLOGY
- The Multiple Sclerosis Functional Composite: A clinically meaningful measure of disability
- (2015) C. H. Polman et al. NEUROLOGY
- Efficacy of combination therapy with erythropoietin and methylprednisolone in clinical recovery of severe relapse in multiple sclerosis
- (2014) Fatemeh Najmi Varzaneh et al. ACTA NEUROLOGICA BELGICA
- Defining the clinical course of multiple sclerosis: The 2013 revisions
- (2014) F. D. Lublin et al. NEUROLOGY
- Targeting erythropoietin for chronic neurodegenerative diseases
- (2013) Zhao Zhong Chong et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Iron depletion induced by bloodletting and followed by rhEPO administration as a therapeutic strategy in progressive multiple sclerosis: A pilot, open-label study with neurophysiological measurements
- (2013) A. Créange et al. NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY
- Recombinant Human Erythropoietin for Treating Treatment-Resistant Depression: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Trial
- (2013) Kamilla W Miskowiak et al. NEUROPSYCHOPHARMACOLOGY
- Unknown
- (2012) Nora Hagemeyer et al. MOLECULAR MEDICINE
- Is there a deleterious effect of erythropoietin in end-stage renal disease?
- (2011) Ajay K. Singh KIDNEY INTERNATIONAL
- Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)
- (2011) DW Langdon et al. Multiple Sclerosis Journal
- Recombinant human erythropoietin delays loss of gray matter in chronic schizophrenia
- (2010) T Wüstenberg et al. MOLECULAR PSYCHIATRY
- Lack of TIMP-1 increases severity of experimental autoimmune encephalomyelitis: Effects of darbepoetin alfa on TIMP-1 null and wild-type mice
- (2009) Michael Thorne et al. JOURNAL OF NEUROIMMUNOLOGY
- A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
- (2009) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recombinant Human Erythropoietin in the Treatment of Acute Ischemic Stroke
- (2009) Hannelore Ehrenreich et al. STROKE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started